Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
08/2005
08/23/2005US6933366 Specificity exchangers that redirect antibodies to bacterial adhesion receptors
08/23/2005US6933352 Amphiphilic compounds having a dendritic branch structure
08/23/2005US6933281 Administering nonapeptides conjugated to drugs or labels, that preferentially targets the lungs, pancreas, skins, eyes, prostate galnds , ovaries, adrenal gland, liver or alimentary canal; drug delivery; medical diagnosis
08/23/2005US6933279 Peptides comprising a class A amphipathic helix when formulated with "D" amino acid residue(s) and/or having protected amino and carboxyl termini
08/23/2005US6933271 Aimed at neoplastic cells with gonadotropin releasing hormone binding sites; anticarcinogenic agents; genetically engineered Pseudomonas Exotoxin
08/23/2005US6932973 Peptides which stimulate the expression of the cytokines of inflammation and promote tissue regeneration
08/23/2005US6932970 administering to a lupus patient a peptide that binds to an anti-double stranded-DNA antibody in the patient, wherein such peptide conataining a D-amino acid sequence of X1-Trp-X1-Tyr-X2, ( X1= Asp or Glu, and X2 = Gly and Ser)
08/18/2005WO2005076009A2 Method for identifying and quantifying of tumour-associated peptides
08/18/2005WO2005075505A1 Peptides that antagonize fpr class receptor mediated signaling
08/18/2005WO2005075448A2 A method for manufacturing optically pure coumaryl amino acids salts and the coumaryl amino acid salts thus obtained
08/18/2005WO2005074626A2 Compositions, methods and uses for a novel family of peptides
08/18/2005WO2005035003A3 Compositions and methods for increasing drug efficiency
08/18/2005WO2005007682A3 A peptide and a pharmaceutical composition, and their medical applications
08/18/2005US20050183169 Transcription regulatory gene and peptide
08/18/2005US20050182242 Microarray comprising double tagged fusion protein for monitoring and classification of polypeptide interactions in preferential species; high-throughput assay
08/18/2005US20050181998 Prion inhibiting peptides and derivatives thereof
08/18/2005US20050181989 Selective substrates for matrix metalloproteinases
08/18/2005US20050181988 antifungal, inhibitory activity on beta -1,3-glucan synthase, treatment of Pneumocystis carinii infection
08/18/2005US20050181984 Acyl derivatives of the echinocandin; aerosol spray; Pneumocystis carinii
08/18/2005US20050181474 Transport peptides and uses therefor
08/18/2005US20050181454 Coupling a solid support derived from polystyrene with N-protected derivative of amino acid, removing N-protecting group, coupling the product thus obtained with N-protected derivative of amino acid; removing protecting group, repeating the procedure, coupling, cyclization
08/18/2005US20050181419 For detection of Mycobacterium tuberculosis infection
08/18/2005US20050180928 peptide having a specific amino acid sequence suppresses initial adhesion of intraoral bacteria to teeth and periodontal tissue and prevents formation of a biofilm in an oral cavity.
08/18/2005CA2554634A1 Compositions, methods and uses for a novel family of peptides
08/18/2005CA2552999A1 Identification of novel ige epitopes
08/17/2005EP1564218A1 Composition for oral cavity
08/17/2005EP1562624A2 Orally administered peptides synergize statin activity
08/17/2005EP1562620A2 Modified cytokines for use in cancer therapy
08/17/2005EP1495045A4 Cytoplasmic transduction peptides and uses thereof
08/17/2005EP1025119B1 Histogranin peptide and their analgesic use
08/17/2005EP0836618B1 Radiometal-binding analogues of leutenizing hormone releasing hormone
08/17/2005CN1215081C Bioactive peptide No.16
08/16/2005US6930091 growth and activity promotion effects on osteoblasts
08/16/2005US6930088 Conformationally constrained backbone cyclized somatostatin analogs
08/16/2005US6930085 G-type peptides to ameliorate atherosclerosis
08/16/2005US6929796 Methods to treat undesirable immune responses
08/16/2005CA2098533C Carrier system against gnrh
08/11/2005WO2005073247A1 Amino acid and peptide conjugates of amiloride and methods of use thereof
08/11/2005WO2005072766A2 Peptides that bind to hsp90 proteins
08/11/2005WO2005054279A8 Delivery peptides, their constructs with active agents and use
08/11/2005WO2005025514A3 Compounds that modulate neuronal growth and their uses
08/11/2005WO2005019457A3 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
08/11/2005WO2004099376A3 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
08/11/2005WO2004068928A3 Bradykinin b2 receptor antagonist peptide from amphibian skin
08/11/2005US20050176993 Urokinase inhibitors, production and use thereof
08/11/2005US20050176648 oligopeptide including enantiomers, stereoisomers and tautomers, used as hepatitis c protease enzyme inhibitors for prophylaxis or prevention of viral diseases
08/11/2005US20050176643 Anti-obesity agents
08/11/2005US20050176641 Long lasting natriuretic peptide derivatives
08/11/2005US20050176637 Administering a peptide having a sequence of QPLALEGSLQK in combination with another polypeptide to treat insulin dependent diabetes mellitus (IDDM or Type 1 diabetes)
08/11/2005US20050176628 Deuterated cyclosporin analogs and their use as immunomodulating agents
08/11/2005US20050176622 secondary binding site of dipeptidyl peptidase IV, its relationship amongst substrates and to the modulation of substrate specificity of dipeptidyl peptidase IV (DP IV, synonym: DPP IV, CD26, EC 3.4.14.5). The application relates further to compounds that bind to the secondary binding site of DP IV
08/11/2005US20050176070 Immunoglobulin array for use in monitoring polypeptide binding
08/11/2005US20050176065 Biarsenical molecules label tetracycsteine polypeptides; orthogonal labelling for observing conformational changes; solid phase synthesis; kits
08/11/2005US20050175633 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV
08/11/2005US20050175631 Hiv vaccine and method of use
08/11/2005US20050175606 Cyclic single-chain trispecific antibody
08/10/2005EP1561425A1 Indocyanine dyes
08/10/2005EP1560933A2 Methods and compositions for treating neurological disorders
08/10/2005EP1560590A2 Synthetic complementary peptides and ophthalmologic uses thereof
08/10/2005EP1560558A1 Use of 3-position cyclosporin derivatives for hair growth
08/10/2005EP0914344B8 ASSAY AND REAGENTS FOR QUANTIFYING hBNP
08/10/2005CN1652819A Attenuation of metapneumovirus
08/10/2005CN1652810A Immunosuppressant compounds, methods and uses related thereto
08/10/2005CN1651457A Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens
08/09/2005US6927208 for the treatment and prevention of AIDS
08/09/2005US6927031 Methods for identifying polypeptide factors interacting with RNA
08/09/2005CA2135278C Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus
08/04/2005WO2005071414A2 Kit for immobilizing organic substance, organic substance-immobilized structure, and manufacturing methods therefor
08/04/2005WO2005071095A2 Fluorogenic kinase assays and substrates for kinases and phosphatases
08/04/2005WO2005070956A1 Analogues of antimicrobial peptide synthesized and produced from gaegurin 5
08/04/2005WO2005070827A2 Fullerene based amino acids
08/04/2005WO2005002516A3 Leukocyte internalized peptide-drug conjugates
08/04/2005WO2004093807A3 Somatostatin vectors
08/04/2005US20050171335 Novel antimicrobial peptide and use thereof
08/04/2005US20050171014 ligand, a linker, and a cytotoxic agent, in which the linker is FALA; cell-targeted cancer therapy
08/04/2005US20050171011 Depsipeptide and congeners thereof for use as immunosuppressants
08/04/2005US20050170436 Inducing specific B cell anergy to an immunogen comprising a conjugate of a nonimmunogenic valency platform molecule and an analog of the immunogen that (a) binds specifically to B cells to which the immunogen binds and (b) lacks the T cell epitope(s) of the immunogen
08/04/2005US20050169911 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate
08/03/2005EP1560026A1 Methods of detecting collagen degradation
08/03/2005EP1559712A1 A method for manufacturing optically active coumaryl amino acid salts and the coumaryl aminoacid salts thus obtained
08/03/2005EP1559374A1 Cyanine dyes
08/03/2005EP1558649A1 Peptides modulating caspase activation
08/03/2005EP1558644A2 A structured peptide scaffold for displaying turn libraries on phage
08/03/2005EP1558630A2 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use
08/03/2005EP1558354A2 Using amines or amino acids as mobile phase modifiers in chromatography
08/03/2005EP1392347B1 Preventing cell death using segments of neural thread proteins
08/03/2005EP1368050A4 Virus derived antimicrobial peptides
08/03/2005EP1131344B1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
08/03/2005CN1650012A Antigens encoded by alternative reading frame from pathogenic viruses
08/03/2005CN1650005A Antimicrobial polypeptide and utizliation thereof
08/03/2005CN1649898A Novel peptides and the application thereof in therapy
08/03/2005CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
08/03/2005CN1649864A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
08/03/2005CN1649625A Conjugates of therapeutic or cytotoxic agents and biologically active peptides
08/03/2005CN1213067C Sequence number9 bioactive peptide
08/03/2005CN1213066C Sequence number8 bioactive peptide
08/03/2005CN1213065C Bioactive peptide No. 7
08/03/2005CN1213064C Bioactive peptide No. 28
08/03/2005CN1213063C Bioactive peptide No.12
08/03/2005CN1213062C Bioactive peptide No. 13
1 ... 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 ... 423